메뉴 건너뛰기
Annals of the New York Academy of Sciences
Volumn 1245, Issue 1, 2011, Pages 48-49
Human stem cell-derived cardiomyocytes for pharmacological and toxicological modeling
Author keywords

Cardiomyocyte; High throughput; In vitro; Stem cell
Indexed keywords

CYCLOPHOSPHAMIDE; TRASTUZUMAB;
EID: 84855246295     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06328.x     Document Type: Article
Times cited : (4)
References (9)
  • 1
    • 0034904645 scopus 로고    scopus 로고
    • Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes
    • Kehat, I., D. Kenyagin-Karsenti, M. Snir, et al 2001. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108: 407-414.
    • (2001) J. Clin. Invest. , vol.108 , pp. 407-414
    • Kehat, I.1    Kenyagin-Karsenti, D.2    Snir, M.3
  • 2
    • 0036244973 scopus 로고    scopus 로고
    • Cardiomyocyte differentiation of mouse and human embryonic stem cells
    • Mummery, C., D. Ward, C.E. van den Brink, et al 2002. Cardiomyocyte differentiation of mouse and human embryonic stem cells. J. Anat. 200: 233-242.
    • (2002) J. Anat. , vol.200 , pp. 233-242
    • Mummery, C.1    Ward, D.2    van den Brink, C.E.3
  • 3
    • 42949088949 scopus 로고    scopus 로고
    • Improved genetic manipulation of human embryonic stem cells
    • Braam, S.R., C. Denning, B.S. van den, et al 2008. Improved genetic manipulation of human embryonic stem cells. Nat. Methods 5: 389-392.
    • (2008) Nat. Methods , vol.5 , pp. 389-392
    • Braam, S.R.1    Denning, C.2    van den, B.S.3
  • 4
    • 36749043230 scopus 로고    scopus 로고
    • Induced pluripotent stem cell lines derived from human somatic cells
    • Yu, J., M.A. Vodyanik, K. Smuga-Otto, et al 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
    • (2007) Science , vol.318 , pp. 1917-1920
    • Yu, J.1    Vodyanik, M.A.2    Smuga-Otto, K.3
  • 5
    • 70350135472 scopus 로고    scopus 로고
    • Cardiomyocyte differentiation of human induced pluripotent stem cells
    • Zwi, L., O. Caspi, G. Arbel, et al 2009. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120: 1513-1523.
    • (2009) Circulation , vol.120 , pp. 1513-1523
    • Zwi, L.1    Caspi, O.2    Arbel, G.3
  • 6
    • 79954523845 scopus 로고    scopus 로고
    • Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation
    • Matsa, E., D. Rajamohan, E Dick, et al 2011. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. Eur. Heart. J. 32: 952-962.
    • (2011) Eur. Heart. J. , vol.32 , pp. 952-962
    • Matsa, E.1    Rajamohan, D.2    Dick, E.3
  • 7
    • 79151484284 scopus 로고    scopus 로고
    • Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy?
    • Foldes, G., M. Mioulane, J.S. Wright, et al 2011. Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy? J. Mol. Cell Cardiol. 50: 367-376.
    • (2011) J. Mol. Cell Cardiol. , vol.50 , pp. 367-376
    • Foldes, G.1    Mioulane, M.2    Wright, J.S.3
  • 8
    • 74949138296 scopus 로고    scopus 로고
    • Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function
    • De Angelis, A., E. Piegari, D. Cappetta, et al 2010. Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation 121: 276-292.
    • (2010) Circulation , vol.121 , pp. 276-292
    • De Angelis, A.1    Piegari, E.2    Cappetta, D.3
  • 9
    • 0035869407 scopus 로고    scopus 로고
    • Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
    • Slamon, D.J., B. Leyland-Jones, S. Shak, et al 2001. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med. 344: 783-792.
    • (2001) N. Engl. J. Med. , vol.344 , pp. 783-792
    • Slamon, D.J.1    Leyland-Jones, B.2    Shak, S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.